Rob Andrew, Ph.D., is the Competitive Intelligence Director for Inflammatory and Rare Diseases at Amgen. With a strong background in the biotech and pharmaceutical industries, Rob previously served as a Biotech Equity Research Associate at William Blair and held postdoctoral and research assistant positions at the University of Chicago and the University of Manchester. Rob earned a Ph.D. in Cellular and Molecular Biology from the University of Manchester and has extensive experience in analyzing investment opportunities and conducting research in the field of neurodegeneration, specifically Alzheimer's disease. Currently, Rob's work involves the assessment of various therapeutic areas, including hematology and immuno-oncology.
This person is not in the org chart
This person is not in any teams
This person is not in any offices